A Review of Sucroferric Oxyhydroxide for the Treatment of Hyperphosphatemia in Patients Receiving Dialysis

Bousher Ava; Al-Makki Akram; Sutton James; Shepler Brian

首页> 外文期刊>Clinical therapeutics >A Review of Sucroferric Oxyhydroxide for the Treatment of Hyperphosphatemia in Patients Receiving Dialysis

【24h】

A Review of Sucroferric Oxyhydroxide for the Treatment of Hyperphosphatemia in Patients Receiving Dialysis

机译：盐酸超铁氢氧化物治疗透析患者高磷酸盐血症的研究进展。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: Sucroferric oxyhydroxide is the newest phosphate binder to receive US Food and Drug Administration approval for patients on dialysis. The purpose of this review is to critically evaluate the studies that have been conducted with this medication and determine where it may fit in the clinician's overall treatment plan for hyperphosphatemia in patients with chronic kidney disease.

机译：目的：羟基氧化苏铁是最新的磷酸盐粘合剂，已获得美国食品和药物管理局批准用于透析患者。这篇综述的目的是严格评估使用这种药物进行的研究，并确定在慢性肾脏疾病患者中高磷酸盐血症的临床治疗总体计划中该药物可能适合的地方。

著录项

来源
《Clinical therapeutics》 |2014年第12期|共12页
作者
Bousher Ava; Al-Makki Akram; Sutton James; Shepler Brian;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词
PA 21; sucroferric oxyhydroxide; Velphoro;

机译：PA 21;羟基氧化亚铁;Velphoro;

相似文献

外文文献
中文文献
专利

1. A Review of Sucroferric Oxyhydroxide for the Treatment of Hyperphosphatemia in Patients Receiving Dialysis [J] . Bousher Ava, Al-Makki Akram, Sutton James, Clinical therapeutics . 2014,第12期

机译：盐酸超铁氢氧化物治疗透析患者高磷酸盐血症的研究进展。
2. Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland [J] . Gutzwiller Florian S., Pfeil Alena M., Ademi Zanfina, PharmacoEconomics . 2015,第12期

机译：从苏格兰国家卫生服务局的角度看，羟基氧化超铁与碳酸司维拉姆相比在治疗透析患者高磷血症中的成本效益
3. Efficacy and tolerability of lanthanum carbonate in treatment of hyperphosphatemia patients receiving dialysis-a systematic review and meta-analysis of randomized controlled trials [J] . HuangW., LiuJ., TangY., Current medical research and opinion . 2014,第1期

机译：碳酸镧治疗接受透析的高磷酸盐血症患者的疗效和耐受性-随机对照试验的系统评价和荟萃分析
4. A deep learning algorithm to prevent burnout risk in Family Caregivers of patients undergoing dialysis treatment [C] . Vania Costa, Martina Messina, Mario Bottone, IEEE International Conference on Cognitive Infocommunications . 2018

机译：一种深度学习算法，可防止接受透析治疗的家庭护理人员的倦怠风险
5. Components of Oral Health in End-Stage Chronic Kidney Disease Patients Undergoing Chronic Dialysis Treatment [D] . Nenova-Nogalcheva, Anna. 2018

机译：口腔健康组分在接受慢性透析治疗的慢性肾病患者中的口腔健康
6. Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis from the Perspective of the National Health Service in Scotland [O] . Florian S. Gutzwiller, Alena M. Pfeil, Zanfina Ademi, -1

机译：从苏格兰国家卫生服务局的角度来看羟基氧化超铁与碳酸司维拉姆相比在治疗透析患者高磷血症中的成本效益
7. PUK19 - COST-UTILITY OF SUCROFERRIC OXYHYDROXIDE FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING DIALYSIS IN CANADA [O] . F. Mills, H. Qureshi, G. Banks, 2018

机译：Puk19 - 用于治疗加拿大透析透析患者的慢性肾病患者的高渗氧化血症的富羟基氧化物的成本用力

A Review of Sucroferric Oxyhydroxide for the Treatment of Hyperphosphatemia in Patients Receiving Dialysis

摘要

著录项

相似文献

相关主题

期刊订阅